David T. Curiel
Affiliations: | 1993-2011 | Medicine | University of Alabama, Birmingham, Birmingham, AL, United States |
2011- | Washington University, Saint Louis, St. Louis, MO |
Area:
vector development, gene therapy vaccine and virotherapy interventions.Website:
http://ocf.wustl.edu/research/cancerbio/curiel/people.aspxGoogle:
"David Terry Curiel" OR "David T Curiel"Bio:
http://btc.wustl.edu/people.html
https://radonc.wustl.edu/people/david-t-curiel-md-phd/
http://hdl.handle.net/11370/dcd8ddf3-011e-413e-8255-228db4f8108a
Mean distance: 20.95 (cluster 59)
Parents
Sign in to add mentorHidde J Haisma | grad student | 2002 | RUG (Cell Biology Tree) | |
(Genetic capsid modification for adenovirus retargeting) | ||||
Herbert Michael Pinedo | grad student | 2002 | RUG (Chemistry Tree) |
Children
Sign in to add traineeC. Ryan Miller | grad student | 1999 | UAB |
Bryan W. Tillman | grad student | 2000 | UAB |
Shannon D. Barker | grad student | 2002 | UAB |
Joshua J. Short | grad student | 2004 | UAB |
Vaibhav Saini | grad student | 2008 | UAB |
Yizhe Tang | grad student | 2005-2009 | UAB |
Lena J. Gamble | grad student | 2010 | UAB |
Miho Murakami | grad student | 2010 | UAB |
Matthew S. Beatty | grad student | 2013 | UAB |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Rice-Boucher PJ, Mendonça SA, Alvarez AB, et al. (2023) Adenoviral vectors infect B lymphocytes in vivo. Molecular Therapy : the Journal of the American Society of Gene Therapy |
Lorincz R, Alvarez AB, Walkey CJ, et al. (2022) In vivo editing of the pan-endothelium by immunity evading simian adenoviral vector. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 158: 114189 |
Lu ZH, Li J, Dmitriev IP, et al. (2022) Efficient Genome Editing Achieved via Plug-and-Play Adenovirus Piggyback Transport of Cas9/gRNA Complex on Viral Capsid Surface. Acs Nano |
Collins LT, Curiel DT. (2021) Synthetic Biology Approaches for Engineering Next-Generation Adenoviral Gene Therapies. Acs Nano |
Lee M, Lu ZH, Shoemaker CB, et al. (2021) Advanced genetic engineering to achieve in vivo targeting of adenovirus utilizing camelid single domain antibody. Journal of Controlled Release : Official Journal of the Controlled Release Society. 334: 106-113 |
Gonzalez-Pastor R, Goedegebuure PS, Curiel DT. (2020) Understanding and addressing barriers to successful adenovirus-based virotherapy for ovarian cancer. Cancer Gene Therapy |
Hassan AO, Kafai NM, Dmitriev IP, et al. (2020) A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2. Cell |
Boucher P, Cui X, Curiel DT. (2020) Adenoviral vectors for in vivo delivery of CRISPR-Cas gene editors. Journal of Controlled Release : Official Journal of the Controlled Release Society |
Lorincz R, Curiel DT. (2020) Advances in Alpha-1 Antitrypsin Gene Therapy. American Journal of Respiratory Cell and Molecular Biology |
Mooney R, Majid AA, Batalla-Covello J, et al. (2020) Erratum: Enhanced Delivery of Oncolytic Adenovirus by Neural Stem Cells for Treatment of Metastatic Ovarian Cancer. Molecular Therapy Oncolytics. 17: 508 |